Cubist Systematic Strategies, LLC Alx Oncology Holdings Inc Transaction History
Cubist Systematic Strategies, LLC
- $15.1 Billion
- Q4 2024
A detailed history of Cubist Systematic Strategies, LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 32,021 shares of ALXO stock, worth $35,223. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,021
Previous 383,512
91.65%
Holding current value
$35,223
Previous $697,000
92.4%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ALXO
# of Institutions
98Shares Held
39.7MCall Options Held
136KPut Options Held
28.8K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$10.7 Million13.33% of portfolio
-
Redmile Group, LLC San Francisco, CA3.69MShares$4.06 Million0.48% of portfolio
-
Tang Capital Management LLC San Diego, CA3.3MShares$3.63 Million0.41% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$2.96 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.5MShares$2.75 Million0.0% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $44.8M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...